P
Prokarium
Biotech & Life Sciences · London, United Kingdom · Founded 2012
Oral vaccines for infectious diseases MoreLess
Prokarium is a biopharmaceutical company that is a leader in the oncology field of microbial immunotherapy. The company's pipeline is designed to advance immuno-oncology by building on the most recent advances in the field. Prokarium's lead program is currently in clinical trials for bladder cancer.
Prokarium's mission is to create novel cancer treatments by applying synthetic biology. The company is also developing oral and thermostable vaccines against Chlamydia trachomatis, a sexually transmitted infection.
Prokarium's business model is focused on the development and commercialization of its proprietary technology platform. The company's target clients are patients with cancer and other diseases that can be treated with microbial immunotherapy.
Keywords: biopharmaceutical, microbial immunotherapy, oncology, synthetic biology, cancer treatments, clinical trials, bladder cancer, vaccines, Chlamydia trachomatis, immuno-oncology
Company overview
Prokarium company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2012
- Headquarters
- London, United Kingdom
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 72.6
Valuation & funding
Prokarium funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLEOther financing | Dec 2025 | $6.3M | — | Flerie Invest | ↗ |
| GRANTOther financing | Aug 2024 | $419K | — | UK Research and Innovation | — |
| LATE VCOther financing | Feb 2023 | $30M | $120M | Undisclosed | ↗ |
| SERIES BOther financing | Oct 2020 | $21M | $84M | Riyadh Valley Company · Korea Investment Partners · Flerie Invest · Future Fund | — |
| EARLY VCOther financing | Oct 2019 | $6.5M | $26M | Wellcome Trust | — |
| EARLY VCOther financing | Feb 2018 | Riyadh Valley Company · Korea Investment Partners · Flerie Invest | ↗ | ||
| GRANTOther financing | Jul 2016 | Undisclosed | — | ||
| FundingOther financing | Aug 2015 | SynbiCITE | — | ||
| GRANTOther financing | Mar 2013 | Biotechnology and Biological Sciences Research Council (BBSRC) | — | ||
| SEEDOther financing | Jan 2012 | Flerie Invest | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $163K | 0% | −$12M | -7065.6% |
| 2025 | $163K | 0% | −$12M | -7065.6% |
| 2024 | $163K | 0% | −$12M | -7065.6% |
| 2023 | $163K | -102% | −$12M | -7065.6% |
| 2022 | −$8M | 0% | −$12M | 143.7% |
| 2021 | −$8M | -1824988.2% | −$8M | 99.2% |
| 2020 | $440 | — | −$6.2M | -1401617% |
Growth signals
Prokarium website traffic
Latest recorded traffic for Prokarium is 1.1K monthly website visits, up 340% over the last three months. Prokarium's team grew 0% over the past year.
Comparisons
Prokarium compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Prokarium's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on Prokarium's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Prokarium has talent and traffic
team presence
In the news
Latest news about Prokarium
Recent press, funding announcements, and product moves mentioning Prokarium — open to read from the original sources.
Market sentiment
What the market is saying about Prokarium
An AI-synthesized read of the highest-engagement posts about Prokarium on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Prokarium’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.